Having survived the cancer which took his father, Graham Heron, from Bovington, is urging more men to act quickly to avoid falling victim to the most common cancer affecting men in the UK.

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and dosage goals.

The Reverend Richard Andrew, president of the Methodist Conference and chair of the Darlington Methodist District, is urging men to undergo ...

A group of doctors who specialize in cancer have detailed four subtle symptoms of the disease that people often overlook. The American Cancer Society predicts 2.1 million people in the US will be ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Three years ago, Maurice Blake was diagnosed with prostate cancer. "I didn't have any of the traditional symptoms, apart from ...

Graham Heron from Dorset urges UK men to get PSA tests for early prostate cancer detection, credits Dorchester Hospital and ...

Prostate cancer is one of the most common cancers affecting men around the world. In many countries, including Germany, it is the most frequently diagnosed cancer in men. Each year, about 65,000 men ...

"Cancer took my dad when he was 56. I was 24 then. I came to believe I would be denied a long life, too. I didn’t admit that to people," columnist Terry Woster writes.

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

The Prostate Cancer Centre, along with Hart, will be hosting its annual men’s health event from 10 a.m. until 4 p.m., ...